Sign in
Taking people in United StatesNo phase

Mouth device for severe obstructive sleep apnea after nerve stimulation did not work

Tests a jaw-advancing mouth device for severe sleep apnea in people unable to use CPAP.

Key facts

Who runs it
Washington University School of Medicine
Where
St Louis, United StatesSee the site
Trial code
Registry title
Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement
Status
Recruiting
People taking part
30 people, planned
Started
29 Jul 2025
Expected to end
1 Feb 2027
Type of study
Interventional
Treatments tested
  • Mandibular advancement device (MAD)
Record updated
19 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obstructive sleep apnea (breathing stops during sleep) whose hypoglossal nerve stimulation (HGNS) therapy did not work. They will test a mouth device that moves the lower jaw forward (MAD).

Age
18 to 70 years
Sex
All sexes
Disease stage
Severe obstructive sleep apnea. People who cannot tolerate CPAP.
Earlier treatment
HGNS therapy must have failed: it was not tolerated, or it did not lower the AHI (breathing pauses per hour) enough by modified Sher criteria. People who could not tolerate a MAD before cannot join. No other sleep apnea treatment is allowed during the study.

Main reasons for not taking part

  • Fewer than 9 healthy teeth per dental arch
  • Chronic blocked nose
  • Insomnia, narcolepsy, restless leg syndrome or other sleep disorders, or medicines for them
  • Substance abuse or unstable psychiatric disorders
  • Current GLP-1 receptor agonist use with ongoing weight loss, or a dose increase in the prior 8 weeks

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Ability to read, write, speak, and understand English
  • Failure of hypoglossal nerve stimulation (HGNS) therapy, defined as intolerance to HGNS or insufficient AHI reduction based on modified Sher criteria while using HGNS
  • Ability to insert and remove the mandibular advancement device (MAD) independently
  • Ability to complete all study assessments and evaluations, including home sleep apnea tests (HSAT)
  • Ability to abstain from any other treatment for obstructive sleep apnea (OSA) during the entire study duration
  • Access to an internet-connected device (phone, tablet, or laptop) with a camera

Who cannot take part

  • Prior intolerance to MAD therapy
  • Previous participation in a trial involving the use of oral appliances
  • Dependence on or frequent use of medications that alter consciousness, respiration, or alertness
  • Insomnia and/or use of medications to treat insomnia
  • Current use of a GLP-1 receptor agonist (e.g., Zepbound, Wegovy, Ozempic, Mounjaro) with ongoing, active weight loss at the time of enrollment, or recent dose escalation within the prior 8 weeks
  • Sleep disorders such as narcolepsy, insomnia, restless leg syndrome, or other disorders affecting sleep, and/or use of medications to treat such disorders
  • Unstable psychiatric disorders
  • Age over 70 years
  • Inability to use a mandibular advancement device (MAD), defined as having fewer than 9 healthy teeth per dental arch
  • Chronic nasal obstruction
  • Substance abuse

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • Washington University School of MedicineSt Louis, United StatesContact: Sara Kukuljan, BS, RNTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the effectiveness, feasibility, and safety of mandibular advancement devices (MAD) for treating severe obstructive sleep apnea (OSA) in patients who are CPAP intolerant and have failed hypoglossal nerve stimulation (HGNS).

The group in the trial

  • Mandibular Advancement Device (MAD)Treatment being tested

    This study is experimental. It involves a single-intervention design where participants who have failed hypoglossal nerve stimulation (HGNS) therapy for moderate to severe obstructive sleep apnea (OSA) will be treated with a mandibular advancement device (MAD).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through
Plain-language title
Mouth device for severe obstructive sleep apnea after nerve stimulation did not workGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07132307, who can take part
Record updated
19 March 2026